<DOC>
	<DOCNO>NCT01986725</DOCNO>
	<brief_summary>In vulvar neoplasia , even minor surgical intervention cause multiple symptom , symptom distress complication , impact woman 's quality life contribute high health care cost . For majority patient , symptom distress reduce adequate treatment provide . This study aim test possible difference impact standardize care WOMAN-PRO II program symptom prevalence woman vulvar neoplasia surgical treatment . In sequential explanatory mixed-methods project , randomize phase II study follow qualitative sub-study . Ninety patient vulvar neoplasia treat surgically participate randomize trial four Swiss hospital one Austrian hospital . After stratification precancer/cancer , woman randomly assign ( 1:2 ratio ) standardize care WOMAN-PRO II program . The standardized care group receive set information leaflet supportive care option clinic . The WOMAN-PRO II program group obtain counseling session specially train gynecology-oncology nurse specialist moment diagnosis , 7 day post-surgery , week two discharge , week twelve week 24 surgery . The primary outcome study symptom prevalence . Secondary outcome collect explorative reason include symptom distress , uncertainty , quality life , social support , resilience , quality care , sociodemographic medical characteristic , post-surgical complication , functional status , cost evaluation process outcomes . Quantitative data collect counsel point time analyze use mixed linear regression analysis . Twenty interview conduct woman WOMAN-PRO II program group . A focus-group interview conduct twelve gynecology-oncology nurse specialist order well understand degree intervention meet individual need well identify remain barrier enablers implementation symptom self-management . Qualitative data analyze use thematic analysis critical hermeneutic reflection . This study evaluate impact WOMAN-PRO II program symptom prevalence , patient-reported outcome clinical parameter , inform design possible phase III study clinical efficacy program .</brief_summary>
	<brief_title>The Impact `` WOMAN-PRO II Program '' Patients With Vulvar Neoplasia Minimize Post-surgical Symptom Prevalence</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<criteria>Diagnosis vulvar intraepithelial neoplasia ( VIN ) vulvar cancer ( primary diagnosis recurrent neoplasia ) Surgical treatment VIN vulvar cancer one designate hospital Age &gt; 18 Patients judged physician gynecologyoncology nurse specialist capable participate trial complete questionnaire due cognitive , linguistic , emotionally physically reason . Patients concurrently psychiatric treatment Terminal illness</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>vulvar neoplasia</keyword>
	<keyword>vulvar cancer</keyword>
	<keyword>vulvar intraepithelial neoplasia</keyword>
	<keyword>self management</keyword>
	<keyword>symptom management</keyword>
</DOC>